A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
about
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureEmerging drugs for the treatment of anxietyThe safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.Pharmacological treatment for generalized anxiety disorder in adults: an update.New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis.Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder.Vortioxetine: a review of its use in major depressive disorder.Vortioxetine for the treatment of major depressive disorder.The efficacy of vortioxetine for the treatment of major depressive disorder.The impact of medication on health-related quality of life in patients with generalized anxiety disorder.A Population Pharmacokinetic-Pharmacodynamic Meta-Analysis of Vortioxetine in Patients with Major Depressive Disorder.Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder.
P2860
Q26796436-FC040C9D-8B34-4430-80D4-A5F2044A6E34Q28083141-5D9CC406-9058-44A0-B0A1-B7C1A87A1151Q31044175-EC8A2436-4666-4012-B653-4EED31A192A5Q34484276-D18B5F33-83D6-48AF-B53B-D9501A5FC2B0Q34676776-56EA1DEE-9153-42DF-9A67-5A83DDC035FEQ36008269-52A5B268-9E5C-4F7D-A684-7C9FA8EDBA2AQ38200656-A09E60D6-638A-40BE-8C67-F6FD7489C7A4Q38242001-775DF133-E8F4-47AA-B9D8-F98CC599F31AQ38244159-999D6474-AA81-4BBA-8E86-18F800C60108Q38270790-91E7202E-3134-4CB7-9B94-C6381A8C49BAQ38291371-3E4165B1-1914-4682-8A72-2D30F0F4D02AQ40366493-50E70B9F-2590-4B13-A6B4-0BC8ACCA648EQ46182025-E4DF1ADC-02B1-4C8D-BE9A-24C7B64063C3Q47573914-22D0788D-0B9F-43E2-BC30-BD8306AA16C5
P2860
A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A randomized, double-blind, fi ...... generalized anxiety disorder.
@en
A randomized, double-blind, fi ...... generalized anxiety disorder.
@nl
type
label
A randomized, double-blind, fi ...... generalized anxiety disorder.
@en
A randomized, double-blind, fi ...... generalized anxiety disorder.
@nl
prefLabel
A randomized, double-blind, fi ...... generalized anxiety disorder.
@en
A randomized, double-blind, fi ...... generalized anxiety disorder.
@nl
P2093
P2860
P356
P1476
A randomized, double-blind, fi ...... generalized anxiety disorder.
@en
P2093
Atul R Mahableshwarkar
Michael Serenko
Paula L Jacobsen
Yinzhong Chen
P2860
P356
10.1002/HUP.2371
P577
2014-01-01T00:00:00Z